Selective arginines are important for the antibacterial activity and host cell interaction of human α-defensin 5

FEBS Letters

Volumn 583, Issue 15, 2009, Pages 2507-2512

  de Leeuw, Erik ^a   Rajabi, Mohsen ^a   Zou, Guozhang ^a   Pazgier, Marzena ^a   Lu, Wuyuan ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Antimicrobial peptide; Human defensin 5; Interleukin 8

Indexed keywords

ALANINE; ALPHA DEFENSIN; ALPHA DEFENSIN 5; ARGININE DERIVATIVE; HISTIDINE; LYSINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; CELL INTERACTION; CONTROLLED STUDY; CROHN DISEASE; HOST CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION;

ALANINE; ALPHA-DEFENSINS; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ARGININE; CROHN DISEASE; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY;

BACTERIA (MICROORGANISMS);

EID: 67849115958     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.06.051     Document Type: Article

References (41)

1. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
2. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
3. Hancock R.E., and Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16 (1998) 82-88
4. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol. 3 (2005) 238-250
5. Hill C.P., Yee J., Selsted M.E., and Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 251 (1991) 1481-1485
6. Hoover D.M., Rajashankar K.R., Blumenthal R., Puri A., Oppenheim J.J., Chertov O., and Lubkowski J. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J. Biol. Chem. 275 (2000) 32911-32918
7. Hoover D.M., Chertov O., and Lubkowski J. The structure of human beta-defensin-1: new insights into structural properties of beta-defensins. J. Biol. Chem. 276 (2001) 39021-39026
8. Pardi A., Zhang X.L., Selsted M.E., Skalicky J.J., and Yip P.F. NMR studies of defensin antimicrobial peptides. 2. Three-dimensional structures of rabbit NP-2 and human HNP-1. Biochemistry 31 (1992) 11357-11364
9. Szyk A., Wu Z., Tucker K., Yang D., Lu W., and Lubkowski J. Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci. 15 (2006) 2749-2760
10. Ganz T., Selsted M.E., Szklarek D., Harwig S.S., Daher K., Bainton D.F., and Lehrer R.I. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Invest. 76 (1985) 1427-1435
11. Wilde C.G., Griffith J.E., Marra M.N., Snable J.L., and Scott R.W. Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J. Biol. Chem. 264 (1989) 11200-11203
12. Singh A., Bateman A., Zhu Q.Z., Shimasaki S., Esch F., and Solomon S. Structure of a novel human granulocyte peptide with anti-ACTH activity. Biochem. Biophys. Res. Commun. 155 (1988) 524-529
13. Gabay J.E., Scott R.W., Campanelli D., Griffith J., Wilde C., Marra M.N., Seeger M., and Nathan C.F. Antibiotic proteins of human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 86 (1989) 5610-5614
14. Jones D.E., and Bevins C.L. Paneth cells of the human small intestine express an antimicrobial peptide gene. J. Biol. Chem. 267 (1992) 23216-23225
15. Jones D.E., and Bevins C.L. Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett. 315 (1993) 187-192
16. Porter E.M., Liu L., Oren A., Anton P.A., and Ganz T. Localization of human intestinal defensin 5 in Paneth cell granules. Infect. Immun. 65 (1997) 2389-2395
17. Wehkamp J., Salzman N.H., Porter E., Nuding S., Weichenthal M., Petras R.E., Shen B., Schaeffeler E., Schwab M., Linzmeier R., Feathers R.W., Chu H., Lima Jr. H., Fellermann K., Ganz T., Stange E.F., and Bevins C.L. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 102 (2005) 18129-18134
18. Wehkamp J., Wang G., Kubler I., Nuding S., Gregorieff A., Schnabel A., Kays R.J., Fellermann K., Burk O., Schwab M., Clevers H., Bevins C.L., and Stange E.F. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J. Immunol. 179 (2007) 3109-3118
19. Wehkamp J., Schmid M., Fellermann K., and Stange E.F. Defensin deficiency, intestinal microbes, and the clinical phenotypes of Crohn's disease. J. Leukoc. Biol. 77 (2005) 460-465
20. de Leeuw E., Burks S.R., Li X., Kao J.P., and Lu W. Structure-dependent functional properties of human defensin 5. FEBS Lett. 581 (2007) 515-520
21. Wu Z., Ericksen B., Tucker K., Lubkowski J., and Lu W. Synthesis and characterization of human alpha-defensins 4-6. J. Pept. Res. 64 (2004) 118-125
22. Ericksen B., Wu Z., Lu W., and Lehrer R.I. Antibacterial activity and specificity of the six human {alpha}-defensins. Antimicrob. Agents Chemother. 49 (2005) 269-275
23. Grigat J., Soruri A., Forssmann U., Riggert J., and Zwirner J. Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J. Immunol. 179 (2007) 3958-3965
24. el Baya A., Bruckener K., and Schmidt M.A. Nonrestricted differential intoxication of cells by pertussis toxin. Infect. Immun. 67 (1999) 433-435
25. Lefkowitz R.J., and Shenoy S.K. Transduction of receptor signals by beta-arrestins. Science 308 (2005) 512-517
26. Zou G., de Leeuw E., Li C., Pazgier M., Li C., Zeng P., Lu W.Y., Lubkowski J., and Lu W. Toward understanding the cationicity of defensins: ARG and LYS versus their noncoded analogs. J. Biol. Chem. 282 (2007) 19653-19665
27. Satchell D.P., Sheynis T., Kolusheva S., Cummings J., Vanderlick T.K., Jelinek R., Selsted M.E., and Ouellette A.J. Quantitative interactions between cryptdin-4 amino terminal variants and membranes. Peptides 24 (2003) 1795-1805
28. Tanabe H., Qu X., Weeks C.S., Cummings J.E., Kolusheva S., Walsh K.B., Jelinek R., Vanderlick T.K., Selsted M.E., and Ouellette A.J. Structure-activity determinants in paneth cell alpha-defensins: loss-of-function in mouse cryptdin-4 by charge-reversal at arginine residue positions. J. Biol. Chem. 279 (2004) 11976-11983
29. Wehkamp J., and Stange E.F. NOD2 mutation and mice. no Crohn's disease but many lessons to learn. Trends Mol. Med. 11 (2005) 307-309
30. Nozaki Y., and Tanford C. The solubility of amino acids and two glycine peptides in aqueous ethanol and dioxane solutions. Establishment of a hydrophobicity scale. J. Biol. Chem. 246 (1971) 2211-2217
31. Dougherty D.A. Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science 271 (1996) 163-168
32. Tokunaga Y., Niidome T., Hatakeyama T., and Aoyagi H. Antibacterial activity of bactenecin 5 fragments and their interaction with phospholipid membranes. J. Pept. Sci. 7 (2001) 297-304
33. Muhle S.A., and Tam J.P. Design of Gram-negative selective antimicrobial peptides. Biochemistry 40 (2001) 5777-5785
34. Yang S.T., Shin S.Y., Lee C.W., Kim Y.C., Hahm K.S., and Kim J.I. Selective cytotoxicity following Arg-to-Lys substitution in tritrpticin adopting a unique amphipathic turn structure. FEBS Lett. 540 (2003) 229-233
35. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., Anderson M., Schroder J.M., Wang J.M., Howard O.M., and Oppenheim J.J. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 286 (1999) 525-528
36. Yang D., Chertov O., and Oppenheim J.J. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37). J. Leukoc. Biol. 69 (2001) 691-697
37. Candille S.I., Kaelin C.B., Cattanach B.M., Yu B., Thompson D.A., Nix M.A., Kerns J.A., Schmutz S.M., Millhauser G.L., and Barsh G.S. A α-defensin mutation causes black coat color in domestic dogs. Science 318 (2007) 1418-1423
38. Territo M.C., Ganz T., Selsted M.E., and Lehrer R. Monocyte-chemotactic activity of defensins from human neutrophils. J. Clin. Invest. 84 (1989) 2017-2020
39. Chertov O., Ueda H., Xu L.L., Tani K., Murphy W.J., Wang J.M., Howard O.M., Sayers T.J., and Oppenheim J.J. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 186 (1997) 739-747
40. Yang D., Chen Q., Chertov O., and Oppenheim J.J. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J. Leukoc. Biol. 68 (2000) 9-14
41. Chertov O., Michiel D.F., Xu L., Wang J.M., Tani K., Murphy W.J., Longo D.L., Taub D.D., and Oppenheim J.J. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271 (1996) 2935-2940